Testing the Implementation of Movement-to-Music in a Community Fitness Center and Blended Onsite and Teleexercise Class

April 20, 2021 updated by: Byron Lai, University of Alabama at Birmingham

Testing the Implementation Efficacy of Movement-to-Music Delivered in a Community-Based Fitness Center and Blended Onsite and Home-based Group Teleexercise Class: A Mixed-Methods Pilot Study.

To prepare for a large scale-up study, the goal of this pilot implementation trial is to examine the feasibility of Movement-to-Music (M2M©) delivery mechanisms through two channels: 1) a group-based M2M© program conducted onsite at a local YMCA; and 2) a blended program that provides Y-M2M© and a home-based M2M© (B-M2M©) via videoconferencing. A key element of this pilot is to examine issues associated with participant-provider interactions, and to better understand the robustness of the technology to deliver a group-based (teleexercise) version of M2M© in the home setting.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

There will be 4 phases to this study. In phase 1, the investigators will explore potential barriers and supports that may affect the delivery of M2M© at one YMCA facility through one-on-one interviews with YMCA staff that have been trained to conduct M2M©.

Phase 2 will include a quantitative monitoring phase. During this phase the 2 delivery mechanisms of M2M© (Y-M2M© and B-M2M©) will be evaluated through assessments of quantitative feasibility metrics before, during, and after the intervention. The intervention will include a convenient sample of 54 participants.

To expand on the findings from the previous quantitative phase, phase 3 will include post-intervention focus group interviews conducted separately for each stakeholder group: all 54 participants, M2M© trainers, research assistants involved with technical support, and YMCA staff that were involved with the project.

During phase 4 (the integrative phase), the researchers will compile the quantitative and qualitative findings for the three primary feasibility metrics (process, resource, and management). These findings will then be comprehensively analyzed by a review panel that will provide suggestions for improvement within each metric. The panel will then discuss the summative findings and vote towards acceptable or not acceptable feasibility.

The 12-week Y-M2M© intervention will be pilot tested at one YMCA facility in Birmingham, AL.The B-M2M© group will be provided with the flexibility of attending the same onsite classes at the YMCA facility as participants in the Y-M2M© group and will also be able to participate in group M2M© teleexercise classes at home that are conducted through Internet video conferencing.

The investigators will use a permuted block randomization design to ensure close balance between the arms across waves and to increase the unpredictability in the upcoming assignment and prevent inadvertent bias. The project statistician will generate the randomization list that will be provided to the project coordinator in sealed envelopes to conceal the allocation. Assessors (health and function assessments done at Lakeshore Foundation) will be blinded to participant assignment and allocation of the arm assignment will not be done until baseline testing and measures are collected.

Primary quantitative outcomes will include those related to process, resources, and management. In summary, these metrics will include measures of adherence, issues that arise with implementation and the efficiency to which they are resolved, and intervention fidelity between the delivery sites. Secondary quantitative outcomes will include estimates of variability in scientific outcomes (physical activity; quality of life; social participation; fitness Measures (cardiorespiratory fitness, muscle strength, lower extremity function; social cognitive theory constructs [Self-efficacy, Outcome expectations, Barriers, Social support]).

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. primary diagnosis of head injury, stroke, MS, spinal cord injury, spina bifida, Parkinson's disease or cerebral palsy conferred by a physician and fits one of the three functional mobility groups (Groups I-III);
  2. between the ages of 19 to 70 yrs.;
  3. physician clearance to participate;
  4. willing to participate in an exercise program 3 times per week;
  5. conversant in and reads English.

Exclusion Criteria:

  1. participated in a similar intervention in the last 6 months;
  2. use of tobacco products in the last 6 months;
  3. cognitive impairment;
  4. active pressure ulcer;
  5. any contraindications to exercise based on the American College of Sports Medicine (ACSM) guidelines;
  6. visual acuity that prevents following a group exercise class;
  7. significant hearing impairment impeding ability to hear music to engage in exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Y-M2M©
a group-based M2M© program conducted onsite at a local YMCA
The Y-M2M© group will receive classes that will be delivered onsite at a YMCA facility. Movement-to-Music (M2M©) is an instructor-guided exercise program that is coupled with music to enhance strength, cardiorespiratory capacity, range of motion, and balance.
Experimental: B-M2M©
a blended program that provides Y-M2M© and a home-based M2M© via videoconferencing
The Y-M2M© group will receive classes that will be delivered onsite at a YMCA facility. Movement-to-Music (M2M©) is an instructor-guided exercise program that is coupled with music to enhance strength, cardiorespiratory capacity, range of motion, and balance.
The B-M2M© group will receive the same onsite M2M© classes as the Y-M2M© group, but they will also be provided with the option of performing home-based M2M© that will be delivered via videoconferencing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase 1: Foreseeable implementation barriers and supports as reported by YMCA trainers
Time Frame: Pre-intervention (week 0)
Prior to conducting the intervention, the investigators will conduct interviews to qualitatively explore YMCA trainers' perceptions of organizational or system factors that can potentially facilitate the adoption of M2M© in YMCAs and tailor the M2M© delivery plan accordingly (using open-ended questions).
Pre-intervention (week 0)
Phase 2: Quantitative feasibility metric (Process outcome #1:Enrollment Rate)
Time Frame: Intervention (weeks 1-12)
Enrollment rate: the number of participants screened / total enrolled
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Process outcome #2: Class Attendance)
Time Frame: Intervention (weeks 1-12)
Attendance to the exercise sessions: total number of sessions attended divided by the total 36 prescribed sessions
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Process outcome #3: Attrition Rate)
Time Frame: Intervention (weeks 1-12)
Attrition rate: number of participants that withdraw from the intervention
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Process outcome #4: Time to complete data collection)
Time Frame: Intervention (weeks 1-12)
Time to complete data collection: time in minutes required to complete data collection (average of both pre- and post-data collection visit times)
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Process outcome #1: Technical difficulties with technology)
Time Frame: Intervention (weeks 1-12)
Technical difficulties with technology: Frequency of issues experienced by participants and trainers
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Resource outcome #2: Resources required by the YMCA)
Time Frame: Intervention (weeks 1-12)
Resources required by the YMCA: # of items purchased for a YMCA M2M class
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Management outcome #1: M2M fidelity between conditions)
Time Frame: Intervention (weeks 1-12)
M2M fidelity between conditions: the frequency of times a deviation from the protocol was observed for both the YMCA and Teleexercise classes.
Intervention (weeks 1-12)
Phase 2: Quantitative feasibility metric (Management outcome #2: Issues with data management)
Time Frame: Intervention (weeks 1-12)
Issues with data management: frequency of issues encountered
Intervention (weeks 1-12)
Phase 3: Qualitative interview exploring stakeholders' perceptions of intervention implementation
Time Frame: Post-Intervention (week 13)
Focus group interviews will be conducted separately for each stakeholder group: all 54 participants, M2M© trainers, research assistants involved with technical support, and YMCA staff that were involved with the project. The semi-structured interviews will explore participants' perceptions regarding the intervention implementation process, resources, and management (using open-ended questions)
Post-Intervention (week 13)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase 2: Quantitative feasibility metric (Scientific outcome #1: Physical Activity)
Time Frame: Intervention (weeks 1 and 12)
Physical Activity: measured via the Godin Leisure-Time Exercise Questionnaire (total score and health-contribution score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome #2: Quality of life)
Time Frame: Intervention (weeks 1 and 12)
Quality of life: measured via the NIH PROMIS 10 Global Health Items (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome #3: Social participation)
Time Frame: Intervention (weeks 1 and 12)
Social participation: measured via the NIH PROMIS Ability to Participate in Social Roles and Activities
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 4: Self-Efficacy)
Time Frame: Intervention (weeks 1 and 12)
Self-Efficacy: measured via the Exercise Self-Efficacy Scale (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 5: Outcome expectations)
Time Frame: Intervention (weeks 1 and 12)
Outcome expectations: measured via the Multidimensional Outcomes Expectations for Exercise Scale (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 6: Barriers)
Time Frame: Intervention (weeks 1 and 12)
Barriers to physical activity: measured via the Barriers in Physical Activity Questionnaire (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 7: Social support)
Time Frame: Intervention (weeks 1 and 12)
Social support: measured via the Social Provision Scale (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 8: Cardiorespiratory fitness)
Time Frame: Intervention (weeks 1 and 12)
Cardiorespiratory fitness: peak oxygen consumption (ml.kg-1.min-1)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 9: Hand-grip strength)
Time Frame: Intervention (weeks 1 and 12)
Cardiorespiratory fitness: peak hand-grip strength (Newtons; both hands)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 10: Lower extremity function)
Time Frame: Intervention (weeks 1 and 12)
Lower extremity function: measured via the Short Physical Performance Battery (total score)
Intervention (weeks 1 and 12)
Phase 2: Quantitative feasibility metric (Scientific outcome # 11: Lower extremity function)
Time Frame: Intervention (weeks 1 and 12)
Lower extremity function: measured via the Timed Up and Go (total score)
Intervention (weeks 1 and 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: James H Rimmer, PhD, University of Alabama at Birmingham
  • Study Director: Hui-Ju Young, PhD, University of Alabama at Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 20, 2021

Primary Completion (Actual)

April 20, 2021

Study Completion (Actual)

April 20, 2021

Study Registration Dates

First Submitted

June 13, 2019

First Submitted That Met QC Criteria

June 17, 2019

First Posted (Actual)

June 19, 2019

Study Record Updates

Last Update Posted (Actual)

April 22, 2021

Last Update Submitted That Met QC Criteria

April 20, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 90DPGE0005-01-00

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will make a de-identified copy of the final data set available after we have completed the final analysis. We will make the data set available to the scientific community through the Inter-University Consortium for Political and Social Research account (which enables free downloads via Internet).

IPD Sharing Time Frame

The data will be uploaded within 12 months of completing the study.

IPD Sharing Access Criteria

Free downloads via the Internet

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Y-M2M©

3
Subscribe